Development and characterisation of novel human multidrug resistant mammary carcinoma lines in vitro and in vivo

International Journal of Cancer

Volumn 72, Issue 5, 1997, Pages 885-891

  Stein, Ulrike ^a   Walther, Wolfgang ^a   Lemm, Margit ^a   Naundorf, Helga ^a   Fichtner, Iduna ^a  

^a MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CISPLATIN; DOXORUBICIN; GLYCOPROTEIN P; METHOTREXATE; MITOXANTRONE; RHODAMINE; VINCRISTINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CARCINOMA; CANCER GRAFT; CANCER INHIBITION; CELL STRAIN MCF 7; CONTROLLED STUDY; CROSS RESISTANCE; FEMALE; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BREAST NEOPLASMS; CISPLATIN; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; METHOTREXATE; MICE; MICE, NUDE; MICROSCOPY, FLUORESCENCE; MITOXANTRONE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; P-GLYCOPROTEIN; RHODAMINES; RNA, MESSENGER; TUMOR CELLS, CULTURED; VAULT RIBONUCLEOPROTEIN PARTICLES; VINCRISTINE;

EID: 0030769447     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19970904)72:5<885::AID-IJC28>3.0.CO;2-6     Document Type: Article

References (22)

1. ABBASZADEGAN, M.R., FUTSCHER, B.W., KLIMECKI, W.T., LIST, A. and DALTON, W.S., Analysis of multidrug resistance-associated protein (MRP) messenger RNA in normal and malignant hematopoietic cells. Cancer Res., 54, 4676-4679 (1994)
2. COLE, S.P., BHARDWAJ, G., GERLACH, J.H., MACKIE, J.E., GRANT, C.E., ALMQUIST, K.C., STEWART, A.J., KURZ, E.U., DUNCAN, A.M. and DEELEY, R.G., Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science, 258, 1650-1654 (1992)
3. FICHTNER, I., STEIN, U., HOFFMANN, J., WINTERFELD, G., PFEIL, D. and HENTSCHEL, M., Characterization of four drug-resistant P388 sublines: resistance/sensitivity in vivo, resistance- and proliferation-markers, immunogenicity. Anticancer Res., 14, 1995-2004 (1994)
4. GIBELLI, N., ZIBERA, C., ASTI, A., MAESTRI, L., BACCHELLA, L., PEDRAZZOLI, P., CALLIGARO, A. and CUNA, G.R., CG5/Dx human breast cancer cell line: characterization of a new doxorubicin-resistant variant. Anticancer Res., 16, 1675-1682 (1996)
5. GUPTA, S. and TSURUO, T., Multidrug resistance in cancer cells: cellular, biochemical molecular and biological aspects. John Wiley & Sons, New York (1996)
6. IZQUIERDO, M.A., SCHEFFER, G.L., FLENS, M.J., SCHROEIJERS, A.B., VAN DER VALK, P. and SCHEPER, R.J., Major vault protein LRP-related multidrug resistance. Europ. J. Cancer, 32A, 979-984 (1996a)
7. IZQUIERDO, M.A., SHOEMAKER, R.H., FLENS, M.J., SCHEFFER, G.L., WU, L., PRATHER, T.R. and SCHEPER, R.J., Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines. Int. J. Cancer, 65, 230-237 (1996b)
8. KOHNO, K., SATO, S., TAKANO, H., MATSUO, K. and KUWANO, M., The direct activation of human multidrug resistance gene (mdr1) by anticancer drugs. Biochem. biophys. Res. Comm., 165, 1415-1421 (1989)
9. LOE, D.W., DEELEY, R.G, and COLE, S.P.C., Biology of the multidrug resistance-associated protein, MRP. Europ. J. Cancer, 32A, 945-957 (1996)
10. R multidrug-resistant human breast tumor xenografts in athymic nude mice. Biochem. Pharmacol., 42, 391-402 (1991)
11. NAUNDORF, H., REWASOWA, E.C., FICHTNER, I., BECKER, M. and GÖRLICH, M., Characterization of two human mammary carcinomas, MT-1 and MT-3, suitable for in vivo testing of ether lipids and their derivatives. Breast Cancer Res. Treat., 23, 87-95 (1992)
12. NOONAN, K.F., BECK, C., HOLZMAYER, T.A., CHIN, J.E., WUNDER, J.S., ANDRULIS, I.L., GAZDAR, A.F., WILLMAN, C.L., GRIFFITH, B., VON HOFF, D.D. and RONINSON, I.B., Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc. nat. Acad. Sci. (Wash.), 87, 7160-7164 (1990)
13. SANFILIPPO, O., RONCHI, E., DE MARCO, C., DI FRONZI, G. and SIL VESTRINI, R., Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxorubicin and vincristine. Europ. J. Cancer, 27, 155-158 (1991)
14. r 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res., 53, 1475-1479 (1993)
15. STEIN, U., WALTHER, W. and SHOEMAKER, R.H., Reversal of multidrug resistance by transduction of cytokine genes into human colon carcinoma cells. J. nat. Cancer Inst., 88, 1383-1392 (1996a)
16. STEIN, U., WALTHER, W. and SHOEMAKER, R.H., Vincristine induction of mutant and wild-type human multidrug-resistance promoters is cell-typespecific and dose-dependent. J. Cancer Res. clin. Oncol., 122, 275-282 (1996b).
17. TAYLOR, C.W., DALTON, W.S., PARRISH, P.R., GLEASON, M.C., BELLAMY, W.T., THOMPSON, F.H., ROE, D.J. and TRENT, J.M., Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line. Brit. J. Cancer, 63, 923-929 (1991)
18. UCHIUMI, T., KOHNO, K., TANIMURA, H., MATSUO, K., SATO, S., UCHIDA, Y. and KUWANO, M., Enhanced expression of the multidrug resistance 1 gene in response to UV light irradiation. Cell Growth Differentiation, 4, 147-157 (1993)
19. WALTHER, W., STEIN, U. and EDER, C., RNA analysis using miniprep RNA in RT-PCR. BioTechniques, 17, 674-675 (1994)
20. WIDMAIER, R., WILDNER, G.P., PAPSDORF, G. and GRAFFI, I., Über eine neue, in vitro unbegrenzt wachsende Zellinie MaTu von Mamma-Tumorzellen des Menschen. Arch. Geschwulstforsch., 44, 1-10 (1974)
21. WU, L., SMYTHE, A.M., STINSON, S.F., MULLENDORE, L.A., MONKS, A., SCUDIERO, D.A., PAUL, K.D., KOUTSOUKOS, A.D., RUBINSTEIN, L.V., BOYD, M.R. and SHOEMAKER, R.H., Multidrug resistant phenotype of disease-oriented panels of human tumor cell lines used for anticancer drug screening. Cancer Res., 52, 3029-3034 (1992)
22. ZHU, Q. and CENTER, M.S., Cloning and sequence analysis of the promoter region of the MRP gene of HL60 cells isolated for resistance to adriablastin. Cancer Res., 54, 4488-4492 (1994)